Aurobindo Pharma informs about updates

18 Dec 2025 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that the United States Food and Drug Administration (US FDA) inspected Unit-IV of APL Healthcare, a wholly owned subsidiary of the Company, situated at Palchur village and part of Palepalem Village Naidupeta Mandal, SPSR Nellore District, 524126, Andhra Pradesh, from December 08 to December 17, 2025. At the end of the current inspection, a ‘Form 483’ was issued with 05 observations which are procedural in nature, and the company will respond to the US FDA within the stipulated timelines. The Company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe. The company will keep the stock exchanges informed if there is any further information relating to the above in the future. 

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1209.90 16.85 (1.41%)
18-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.35
Dr. Reddys Lab 1279.60
Cipla 1499.10
Zydus Lifesciences 913.85
Lupin 2118.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×